⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LGVN News
Longeveron Inc. Common Stock
Form 8-K
sec.gov
LGVN
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed
globenewswire.com
FBLG
FATE
MESO
LGVN
A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.
prnewswire.com
MESO
LGVN
LCTX
MNKD
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
globenewswire.com
LGVNR
LGVN
Form 8-K
sec.gov
LGVN
Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026
globenewswire.com
LGVNR
LGVN
Longeveron Announces Closing of Private Placement of up to $30 Million
globenewswire.com
LGVNR
LGVN
Longeveron Announces Private Placement of up to $30 Million
globenewswire.com
LGVNR
LGVN
Form 8-K
sec.gov
LGVN
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
prnewswire.com
FBLG
MESO
LGVN
FATE